Narrative Review: Clarkson Disease-Systemic Capillary Leak Syndrome

Por Druey, Kirk M., Greipp, Philip R.
Publicado em 2010

Plasma Cell Labeling Index in the Evaluation of Smoldering (Asymptomatic) Multiple Myeloma

Por Madan, Sumit, Kyle, Robert A., Greipp, Philip R.
Publicado em 2010

Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survival

Por Larsen, Jeremy T., Chee, Cheng E., Lust, John A., Greipp, Philip R., Rajkumar, S. Vincent
Publicado em 2011

A Phase II Trial of Autologous Stem Cell Transplant Followed by Mini-Allogeneic Stem Cell Transplant for the Treatment of Multiple Myeloma: An Analysis of Eastern Cooperative Oncol...

Por Vesole, David H., Zhang, Lijun, Flomenberg, Neal, Greipp, Philip R., Lazarus, Hillard M.
Publicado no Biol Blood Marrow Transplant (2009)

Primary therapy with single agent bortezomib as induction, maintenance, and re-Induction in patients with high risk myeloma: results of the ECOG E2A02 trial

Por Dispenzieri, Angela, Jacobus, Susanna, Vesole, David H., Callandar, Natalie, Fonseca, Rafael, Greipp, Philip R.
Publicado em 2010

Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial

Por Gertz, Morie A., Abonour, Rafat, Heffner, Leonard T., Greipp, Philip R., Uno, Hajime, Rajkumar, S. V.
Publicado em 2009

Infection and Killing of Multiple Myeloma by Adenoviruses

Por Senac, Julien S., Doronin, Konstantin, Russell, Stephen J., Jelinek, Diane F., Greipp, Philip R., Barry, Michael A.
Publicado em 2010

Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): A trial of the Eastern Cooperative Oncology Group()

Por Lacy, Martha Q., Jacobus, Susanna, Blood, Emily A., Kay, Neil E., Rajkumar, S. Vincent, Greipp, Philip R.
Publicado em 2009

The Treatment of Multiple Myeloma Utilizing Vincristine, Carmustine (BCNU), Melphalan, Cyclophosphamide, and Prednisone (VBMCP) Alternating with High-Dose Cyclophosphamide and Alph...

Por Kyle, Robert A., Jacobus, Susanna, Fridenberg, William R., Slabber, Coenraad Frederik, Rajkumar, S. Vincent, Greipp, Philip R.
Publicado em 2009

Species D Adenoviruses as Oncolytics Against B Cell Cancers

Por Chen, Christopher Y., Senac, Julien S., Weaver, Eric A., May, Shannon M., Jelinek, Diane F., Greipp, Philip, Witzig, Thomas, Barry, Michael A.
Publicado em 2011

Idiopathic Systemic Capillary Leak Syndrome (Clarkson's Disease): The Mayo Clinic Experience

Por Kapoor, Prashant, Greipp, Patricia T., Schaefer, Eric W., Mandrekar, Sumithra J., Kamal, Arif H., Gonzalez-Paz, Natalia C., Kumar, Shaji, Greipp, Philip R.
Publicado em 2010

R-(−)–gossypol (AT-101) activates programmed cell death in multiple myeloma cells

Por Kline, Michael P., Rajkumar, S. Vincent, Timm, Michael M., Kimlinger, Teresa K., Haug, Jessica L., Lust, John A., Greipp, Philip R., Kumar, Shaji
Publicado em 2008

Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome)

Por Xie, Zhihui, Ghosh, Chandra C., Patel, Roshni, Iwaki, Shoko, Gaskins, Donna, Nelson, Celeste, Jones, Nina, Greipp, Philip R., Parikh, Samir M., Druey, Kirk M.
Publicado em 2012

Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy

Por Gertz, Morie A., Lacy, Martha Q., Dispenzieri, Angela, Greipp, Philip R., Litzow, Mark R., Henderson, Kimberly J., Van Wier, Scott A., Ahmann, Greg J., Fonseca, Rafael
Publicado em 2005

Appraisal of immunoglobulin free light chain as a marker of response

Por Dispenzieri, Angela, Zhang, Lijun, Katzmann, Jerry A., Snyder, Melissa, Blood, Emily, DeGoey, Roberta, Henderson, Kimberly, Kyle, Robert A., Oken, Martin M., Bradwell, Arthur R., Greipp, Philip R.
Publicado em 2008

Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma

Por Nowakowski, Grzegorz S., Witzig, Thomas E., Dingli, David, Tracz, Michal J., Gertz, Morie A., Lacy, Martha Q., Lust, John A., Dispenzieri, Angela, Greipp, Philip R., Kyle, Robert A., Rajkumar, S. Vincent
Publicado em 2005

Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system

Por Dingli, David, Nowakowski, Grzegorz S., Dispenzieri, Angela, Lacy, Martha Q., Hayman, Suzanne R., Rajkumar, S. Vincent, Greipp, Philip R., Litzow, Mark R., Gastineau, Dennis A., Witzig, Thomas E., Gertz, Morie A.
Publicado em 2006

Proteasome β Subunit Pharmacogenomics: Gene Resequencing and Functional Genomics

Por Wang, Liewei, Kumar, Shaji, Fridley, Brooke L., Kalari, Krishna R., Moon, Irene, Pelleymounter, Linda L., Hildebrandt, Michelle A.T., Batzler, Anthony, Eckloff, Bruce W., Wieben, Eric D., Greipp, Philip R.
Publicado em 2008

Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma

Por Madan, Sumit, Lacy, Martha Q., Dispenzieri, Angela, Gertz, Morie A., Buadi, Francis, Hayman, Suzanne R., Detweiler-Short, Kristen, Dingli, David, Zeldenrust, Steven, Lust, John, Greipp, Philip R., Rajkumar, S. Vincent, Kumar, Shaji
Publicado em 2011

The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome

Por Driscoll, James J., Pelluru, Dheeraj, Lefkimmiatis, Konstantinos, Fulciniti, Mariateresa, Prabhala, Rao H., Greipp, Philip R., Barlogie, Bart, Tai, Yu-Tzu, Anderson, Kenneth C., Shaughnessy, John D., Annunziata, Christina M., Munshi, Nikhil C.
Publicado em 2010